These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 8676808

  • 1. Effects of lipids on the pathogenesis of progressive renal failure: role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in the prevention of glomerulosclerosis.
    Guijarro C, Keane WF.
    Miner Electrolyte Metab; 1996; 22(1-3):147-52. PubMed ID: 8676808
    [Abstract] [Full Text] [Related]

  • 2. Lipids and progressive renal failure.
    Keane WF.
    Wien Klin Wochenschr; 1996; 108(14):420-4. PubMed ID: 8784983
    [Abstract] [Full Text] [Related]

  • 3. Cholesterol synthesis inhibitors inhibit more than cholesterol synthesis.
    Kasiske BL, O'Donnell MP, Kim Y, Atluru D, Keane WF.
    Kidney Int Suppl; 1994 Feb; 45():S51-3. PubMed ID: 8158898
    [Abstract] [Full Text] [Related]

  • 4. The mevalonate pathway: importance in mesangial cell biology and glomerular disease.
    O'Donnell MP, Kasiske BL, Kim Y, Atluru D, Keane WF.
    Miner Electrolyte Metab; 1993 Feb; 19(3):173-9. PubMed ID: 8232104
    [Abstract] [Full Text] [Related]

  • 5. Lovastatin inhibits proliferation of rat mesangial cells.
    O'Donnell MP, Kasiske BL, Kim Y, Atluru D, Keane WF.
    J Clin Invest; 1993 Jan; 91(1):83-7. PubMed ID: 8423236
    [Abstract] [Full Text] [Related]

  • 6. Low-density lipoprotein-induced expression of interleukin-6, a marker of human mesangial cell inflammation: effects of oxidation and modulation by lovastatin.
    Massy ZA, Kim Y, Guijarro C, Kasiske BL, Keane WF, O'Donnell MP.
    Biochem Biophys Res Commun; 2000 Jan 19; 267(2):536-40. PubMed ID: 10631097
    [Abstract] [Full Text] [Related]

  • 7. Lovastatin-induced proliferation inhibition and apoptosis in C6 glial cells.
    Choi JW, Jung SE.
    J Pharmacol Exp Ther; 1999 Apr 19; 289(1):572-9. PubMed ID: 10087052
    [Abstract] [Full Text] [Related]

  • 8. Lovastatin inhibits lipopolysaccharide-induced NF-kappaB activation in human mesangial cells.
    Guijarro C, Kim Y, Schoonover CM, Massy ZA, O'Donnell MP, Kasiske BL, Keane WF, Kashtan CE.
    Nephrol Dial Transplant; 1996 Jun 19; 11(6):990-6. PubMed ID: 8671958
    [Abstract] [Full Text] [Related]

  • 9. Effect of lipids on glomerular injury and progression of renal disease.
    Keane WF.
    Verh K Acad Geneeskd Belg; 1994 Jun 19; 56(2):91-104. PubMed ID: 8048270
    [Abstract] [Full Text] [Related]

  • 10. Collagen secretion and growth of mesangial cells require geranylgeranylpyrophosphate.
    Nishimura M, Tanaka T, Yasuda T, Kurakata S, Kitagawa M, Yamada K, Saito Y, Hirai A.
    Kidney Int; 1999 Feb 19; 55(2):520-8. PubMed ID: 9987076
    [Abstract] [Full Text] [Related]

  • 11. Effects of fungal statins on high-glucose-induced mouse mesangial cell hypocontractility may involve filamentous actin, t-complex polypeptide 1 subunit beta, and glucose regulated protein 78.
    Hwang JC, Chang LC, Lin YF, Shui HA, Chen JS.
    Transl Res; 2010 Aug 19; 156(2):80-90. PubMed ID: 20627192
    [Abstract] [Full Text] [Related]

  • 12. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
    Pappu AS, Bacon SP, Illingworth DR.
    J Lab Clin Med; 2003 Apr 19; 141(4):250-6. PubMed ID: 12677170
    [Abstract] [Full Text] [Related]

  • 13. Direct inhibitory effects of simvastatin on matrix accumulation in cultured murine mesangial cells.
    Nogaki F, Muso E, Yashiro M, Kasuno K, Kamata T, Ono T, Sasayama S.
    Kidney Int Suppl; 1999 Jul 19; 71():S198-201. PubMed ID: 10412775
    [Abstract] [Full Text] [Related]

  • 14. Effect of simvastatin on proliferative nephritis and cell-cycle protein expression.
    Yoshimura A, Nemoto T, Sugenoya Y, Inui K, Watanabe S, Inoue Y, Sharif S, Yokota N, Uda S, Morita H, Ideura T.
    Kidney Int Suppl; 1999 Jul 19; 71():S84-7. PubMed ID: 10412745
    [Abstract] [Full Text] [Related]

  • 15. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
    McAnally JA, Gupta J, Sodhani S, Bravo L, Mo H.
    Exp Biol Med (Maywood); 2007 Apr 19; 232(4):523-31. PubMed ID: 17392488
    [Abstract] [Full Text] [Related]

  • 16. [HMG-CoA reductase inhibitors: anti-atherosclerotic effects other than lipid-lowering].
    Fujita R, Matsushima T.
    Nihon Rinsho; 1999 Dec 19; 57(12):2821-5. PubMed ID: 10638219
    [Abstract] [Full Text] [Related]

  • 17. Effect of pravastatin on type IV collagen secretion and mesangial cell proliferation.
    Nishimura M, Tanaka T, Yasuda T, Kurakata S, Kitagawa M, Yamada K, Saito Y, Hirai A.
    Kidney Int Suppl; 1999 Jul 19; 71():S97-100. PubMed ID: 10412748
    [Abstract] [Full Text] [Related]

  • 18. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
    Davis HR, Pula KK, Alton KB, Burrier RE, Watkins RW.
    Metabolism; 2001 Oct 19; 50(10):1234-41. PubMed ID: 11586500
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro.
    Flint OP, Masters BA, Gregg RE, Durham SK.
    Toxicol Appl Pharmacol; 1997 Jul 19; 145(1):91-8. PubMed ID: 9221828
    [Abstract] [Full Text] [Related]

  • 20. Human mesangial cell production of monocyte chemoattractant protein-1: modulation by lovastatin.
    Kim SY, Guijarro C, O'Donnell MP, Kasiske BL, Kim Y, Keane WF.
    Kidney Int; 1995 Aug 19; 48(2):363-71. PubMed ID: 7564103
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.